Th17 cell‐derived IL‐17A and tumor cell‐derived G‐CSF activate ERK‐NF‐κB and JAK‐STAT3 signaling pathways to induce FasL and PD‐L2 expression on neutrophils. The gene discussed is CSF3; the disease is neoplasm.